Evolv Technologies Holdings Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $171.4M+65.1% YoYTTM through 30 Jun 2026
Net Income -$5.2MTTM through 30 Jun 2026
Free Cash Flow -$12.7MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 51.6% |
| EBITDA Margin | -5.0% |
| Operating Margin | -33.2% |
| Net Margin | -3.1% |
Returns
-27.7%ROE
-10.9%ROA
Balance Sheet Health
Debt / Equity0.25x
Current Ratio1.20x
Net Debt-$39Mnet cash position
Cash & Equivalents$52.7M
Quality Metrics
Altman Z-Score1.30
Piotroski F-Score4 / 9
FCF Margin-7.4%
Rule of 40-4.1
Earnings-Beat Rate66.7%
Multi-Year Trend
RevenueFY2025: $145.9M
Diluted EPS-$0.02TTMFY2025: $-0.20
Dividend
No dividend
Capital Allocation
R&D Spend$22.7M
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.